Supporting The Discovery & Development Of Ocular Drug Products

An integrated approach to ophthalmology research is key to navigating the development process with speed and reduced costs. Charles River has critical understanding of ocular diseases and the technical ability to advance your drug products faster and more affordably.

Intraocular dosing presents a unique set of challenges across the various species used in research. Critical background knowledge of interspecies differences in ocular anatomy/physiology and specialized training in microsurgical techniques are essential. Utilizing Charles River's complete suite of specialized diagnostic equipment required for detailed assessment of the ocular response to administration of novel compounds and devices helps reduce complications for delivering intraocular doses.

The experienced ocular pathology team at Charles River offers the knowledge and expertise to perform specialized pathological assessments of ocular tissues within several key areas, including routine paraffin or cryo-sectioning, immunohistochemistry, and electron microscopy. Learn more about how a partner offering stand-alone efficacy and safety studies, as well as general and specialty toxicology programs, can guide you through development as efficiently as possible.